Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
Tags
biotech
celgene
4
×
life sciences
national blog main
new york
new york blog main
new york top stories
4
×
anemia
beta-thalassemia
boston blog main
bristol-myers squibb
fda
luspatercept
multiple sclerosis
ozanimod
rare diseases
acceleron pharma
acceleron pharmaceuticals
acquisition
amgen
bcma
bluebird bio
boston top stories
buyout
clinical trials
clinical trials fda
drug discovery
drugs
giovanni caforio
glaxosmithkline
idecabtagene vicleucel
johnson & johnson
life science
lisocabtagene maraleucel
m&a
merger
ms
multiple myeloma
myelodysplastic syndrome
myelodysplastic syndrome (mds)
What
approval
4
×
drug
fda
4
×
celgene
experimental
blood
cell
multiple
pipeline
acceleron
acquisition
added
amid
anemia
application
asks
assets
based
bcma
bid
bristol
celgene’s
cited
declined
delay
detour
developed
disease
disorder
drama
filed
files
hit
info
key
levels
low
monday
ms
myeloma
Language
unset
Current search:
approval
×
fda
×
" new york top stories "
×
celgene
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}